Literature DB >> 21247262

Is there a common SUV threshold in oncological FDG PET/CT, at least for some common indications? A retrospective study.

Nghi C Nguyen1, Aarti Kaushik, Michael K Wolverson, Medhat M Osman.   

Abstract

PURPOSE: We retrospectively compared the maximum standard uptake value (SUVmax) of FDG PET in four different sites to evaluate whether a common diagnostic SUVmax threshold may exist in these tumor locations. We further postulate that the SUVmax thresholds are higher in thoracic lesions than in extrathoracic lesions.
MATERIAL AND METHODS: N = 143 patients in four subgroups underwent a FDG PET/CT: a) 42 patients for solitary pulmonary nodules (SPNs) characterization with b) respective mediastinal lymph nodes (LNs), c) 65 patients for LN staging of head and neck cancer, and d) 36 cancer patients diagnosed with adrenal lesions. Receiver operating characteristics of SUVmax values were evaluated.
RESULTS: The SUVmax were statistically significantly greater in malignant than in benign lesions. For SPNs and mediastinal LNs, a SUVmax > 3.6 each resulted in a sensitivity of 81% and 87%, and a specificity of 94% and 89%. For cervical LNs and adrenal glands, a SUVmax > 2.2 each showed a sensitivity of 98% and 100%, and a specificity of 83% and 93%.
CONCLUSION: A common SUVmax threshold did not exist in the four studied subgroups. The variable FDG uptake in SPNs and mediastinal LNs are associated with the high prevalence of inflammation/infection within the chest. Similar SUVmax thresholds however may exist for extrathoracic regions where the prevalence of inflammation/infection is low.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21247262     DOI: 10.3109/0284186X.2010.550933

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  23 in total

Review 1.  Positron Emission Tomography (PET) in Oncology.

Authors:  Andrea Gallamini; Colette Zwarthoed; Anna Borra
Journal:  Cancers (Basel)       Date:  2014-09-29       Impact factor: 6.639

2.  PET-CT evaluation of solitary pulmonary nodules: correlation with maximum standardized uptake value and pathology.

Authors:  Yee Ting Sim; Yong Geng Goh; Mary Frances Dempsey; Sai Han; Fat Wui Poon
Journal:  Lung       Date:  2013-09-08       Impact factor: 2.584

3.  PET-derived tumor metrics predict DLBCL response and progression-free survival.

Authors:  Prioty Islam; Jordan Goldstein; Christopher R Flowers
Journal:  Leuk Lymphoma       Date:  2019-02-04

Review 4.  Imaging of solitary pulmonary nodule-a clinical review.

Authors:  Yee Ting Sim; Fat Wui Poon
Journal:  Quant Imaging Med Surg       Date:  2013-12

5.  The clinical value of texture analysis of dual-time-point 18F-FDG-PET/CT imaging to differentiate between 18F-FDG-avid benign and malignant pulmonary lesions.

Authors:  Masatoyo Nakajo; Megumi Jinguji; Masaya Aoki; Atsushi Tani; Masami Sato; Takashi Yoshiura
Journal:  Eur Radiol       Date:  2019-11-14       Impact factor: 5.315

6.  Cholinergic PET imaging in infections and inflammation using 11C-donepezil and 18F-FEOBV.

Authors:  Nis Pedersen Jørgensen; Aage K O Alstrup; Frank V Mortensen; Karoline Knudsen; Steen Jakobsen; Line Bille Madsen; Dirk Bender; Peter Breining; Mikkel Steen Petersen; Mariane Høgsberg Schleimann; Frederik Dagnæs-Hansen; Lars C Gormsen; Per Borghammer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-10-26       Impact factor: 9.236

7.  A multimodality segmentation framework for automatic target delineation in head and neck radiotherapy.

Authors:  Jinzhong Yang; Beth M Beadle; Adam S Garden; David L Schwartz; Michalis Aristophanous
Journal:  Med Phys       Date:  2015-09       Impact factor: 4.071

Review 8.  Accuracy of FDG-PET to diagnose lung cancer in areas with infectious lung disease: a meta-analysis.

Authors:  Stephen A Deppen; Jeffrey D Blume; Clark D Kensinger; Ashley M Morgan; Melinda C Aldrich; Pierre P Massion; Ronald C Walker; Melissa L McPheeters; Joe B Putnam; Eric L Grogan
Journal:  JAMA       Date:  2014-09-24       Impact factor: 56.272

9.  Comparing the diagnostic value of 18F-FDG-PET/CT versus CT for differentiating benign and malignant solitary pulmonary nodules: a meta-analysis.

Authors:  Yuzhu Jia; Wanfeng Gong; Zhiping Zhang; Gaofeng Tu; Jiapeng Li; Fanfan Xiong; Hongtao Hou; Yunyi Zhang; Meiqian Wu; Liping Zhang
Journal:  J Thorac Dis       Date:  2019-05       Impact factor: 2.895

10.  Quantitative volumetric metabolic measurement of solitary pulmonary nodules by F-18 fluorodeoxyglucose positron emission tomography-computed tomography.

Authors:  Tarık Şengöz; Dogangün Yüksel; Olga Yaylalı; Haydar Arslan; Ferda Bir
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2019-10-23       Impact factor: 0.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.